RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...
Vietnam Investment Review on MSN10d
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development AcceleratesRecently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development ...
TechInvention and Belgium-based Quantoom Biosciences have entered a partnership to enhance the local manufacturing of mRNA ...
Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...
Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...
Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking ...
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA ...
2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback